Sterling Infrastructure Shares Rise 12% Over Past Month on Data Center Demand
Sterling Infrastructure (STRL) shares rose 12% over the past month, driven by surging data center demand and a growing E-Infrastructure backlog.
Every story explained in plain English, with the prices that matter beside it.
Sterling Infrastructure (STRL) shares rose 12% over the past month, driven by surging data center demand and a growing E-Infrastructure backlog.
OpenWorld, Inc. signed a non-binding term sheet to arrange up to $130 million in digital tokenized financing secured by BeyondAI's intellectual property.
CERo Therapeutics Holdings is selling its operating unit to SRX Global for stock and debt relief to reduce leverage and reposition the company.
AIB Data Centers Inc (AMEX:AIB) signed a 50MW deal with Nebius and plans to fund its CLT1 project without issuing corporate equity.
LightPath Technologies appointed Scott Payette to scale G5 Infrared camera production and convert its order backlog into revenue.
Lantern Pharma secured regulatory clearances in Taiwan to advance the Phase 2 trial of its lung cancer drug candidate, LP-300, into its second part.
Western Star Resources announced tungsten assay results at its Eagle Point project and plans a 17-hole drilling program.
BioNexus Gene Lab Corp. has signed a deal for an exclusive Malaysian healthcare AI license targeting a RM1B public digitalization initiative.
Ondas Inc. booked over $270 million in orders since June 30, expanding its backlog and providing revenue visibility into 2027.
OpenWorld, Inc. signed a tentative agreement for a tokenization deal worth up to $130 million, highlighting its real-world asset strategy.
QT Imaging distributor NXC Imaging signed a national purchasing agreement with Premier, expanding breast scanner access to about 4,400 hospitals.
Halozyme Therapeutics secured a European court injunction blocking Merck's Keytruda SC, strengthening its IP position and disrupting a rival product.
Ultragenyx Pharmaceutical is selling its FDA priority review voucher for $210 million to secure non-dilutive capital and fund its drug pipeline.
Sotkamo Silver found mineralization in all seven analyzed drill holes, pointing to a potential mine life extension at its western drilling program.
5E Advanced Materials targets 40 million dollars in steady-state annual Adjusted EBITDA following its Searles Valley acquisition integration.
AbbVie received two FDA Breakthrough Therapy Designations for its oncology drug Temab-A, which could speed up development in large cancer markets.
Töysän Säästöpankkisäätiö has fully exited its position in Oma Savings Bank Plc, reducing its holdings and voting rights to zero percent.
Mint Incorporation Limited has secured a supply and license agreement in Europe worth up to €3 million, starting with an initial €450,000 order.
RenovoRx enrolled the first patient in a pancreatic cancer clinical trial to evaluate its TAMP therapy delivery platform before surgery.
Fiserv has rolled out over 1,000 Clover POS terminals at Hard Rock Stadium, marking a key enterprise win that could boost recurring transaction volumes.